Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1130659 | 0.94 | CYP3A4 (0.56) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL1396400 | 0.92 | CYP3A4 (0.67) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL29975843 | 0.90 | CYP3A4 (0.50) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL211654 | 0.90 | CYP3A4 (0.50) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL374838 | 0.89 | CYP3A4 (0.58) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL8139264 | 0.89 | CYP3A4 (0.56) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL1396327 | 0.87 | CYP3A4 (0.56) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL374837 | 0.86 | CYP3A4 (0.63) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL2858280 | 0.86 | CYP3A4 (0.68) | CYP3A4TSHRTRPA1CYP1A2TDP1 | |
| SCHEMBL23825209 | 0.85 | CYP3A4 (0.69) | CYP3A4TSHRTRPA1CYP1A2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | ENEVATE CORP (US) | 2024-10-03 | — | — | US | claimed |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION | 2021-08-12 | — | — | US | claimed |
| WO-2021158366-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION (US) | 2021-08-12 | — | — | WO | claimed |
| EP-1439155-B1 | Reaction-resin mortar for two-component systems | FISCHERWERKE GMBH & CO KG (DE) | 2013-08-21 | — | — | EP | claimed |
| US-5998510-A | POLYESTERURETHANE COPOLYMER | PREMIX, INC. (US) | 1999-12-07 | — | — | US | claimed |
| US-4728577-A | BINDER OF CELLULOSE DERIVATIVE, POLYURETHANE AND POLYISOCYANATE | FUJI PHOTO FILM CO., LTD. (JP) | 1988-03-01 | — | — | US | claimed |
| US-4664979-A | DURABLE MAGNETIC TAPES | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-12 | — | — | US | claimed |
| EP-0048117-A2 | In-mold coating compositions containing a non-isocyanate-reactive unsaturated resin, a non-isocyanate-reactive monomer and a free isocyanate-containing compound | ICI AMERICAS INC. (US) | 1982-03-24 | — | — | EP | claimed |
| US-4268649-A | PHENOL-FORMALDEHYDE RESIN, ISOCYANATE, AMINE | RUTGERSWERKE AKTIENGESELLSCHAFT (DE) | 1981-05-19 | — | — | US | claimed |
| US-4201835-A | PHENOLIC RESIN, POLYISOCYANATE, AMINE | RUTGERSWERKE AKTIENGESELLSCHAFT (DE) | 1980-05-06 | — | — | US | claimed |
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | ENEVATE CORP (US) | 2024-10-03 | — | — | US | disclosed |
| US-20240228764-A9 | AQUEOUS DISPERSIONS CONTAINING CATIONIC POLYVINYL ALCOHOL MODIFIED POLYMER PARTICLES AND AQUEOUS ELECTROCOATING MATERIALS CONTAINING SAID DISPERSIONS | BASF COATINGS GMBH (DE) | 2024-07-11 | — | — | US | disclosed |
| US-20240199787-A1 | METHOD FOR THE PRODUCTION OF AN ISOCYANATE-GROUP TERMINATED POLYOXAZOLIDINONE COMPOSITION | COVESTRO DEUTSCHLAND AG (DE) | 2024-06-20 | — | — | US | disclosed |
| US-20240199789-A1 | POLYURETHANE FOAM AND CUSHIONING MATERIAL | INOAC CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| WO-2024127252-A1 | CYCLIC IMIDES AND ADHESIVE COMPOSITIONS INCLUDING THEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-06-20 | — | — | WO | disclosed |
| US-4074007-A | Coating composition | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-02-14 | — | — | US | disclosed |
| US-4049871-A | POLYURETHANE, ALKYD RESIN, POLYISOCYANATE BINDER | FUJI PHOTO FILM CO., LTD. (JA) | 1977-09-20 | — | — | US | disclosed |
| US-4032574-A | PRODUCTION OF POLYETHERPOLYOLS USEFUL IN PREPARING RIGID POLYURETHANE FOAMS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-06-28 | — | — | US | disclosed |
| US-4018743-A | Process for preparing triketoimidazolidines | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-19 | — | — | US | disclosed |
| US-3969290-A | POLYMERS FROM OXAMIDIC ESTERS, POLYISOCYANATES, AND POLYBASIC CARBOXYLIC ACIDS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885TRPA1 810/4885 |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885TRPA1 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.